bluebird bio, Inc.
USD4.97
+0.00 (+0.00%)
CEO
Andrew Obenshain
IPO Date
2013-06-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.97
Prev. Close
$4.97
Day Low
$4.97
Day High
$4.97
52W Low
$3.20
52W High
$28.60
Market Cap
$0.05B
Volume
1.25M
| 2,500 |
| $3.00 |
| 3 Jun 2025 | Vittiglio Joseph | Chief Business & Legal Officer | A-Award | Acquired | 2,500 | $3.00 |
| 3 Jun 2025 | Agwunobi John O | director | U-Tender | Disposed | 1,323 | $3.00 |
| 3 Jun 2025 | Agwunobi John O | director | D-Return | Disposed | 1,245 | $3.00 |
| 3 Jun 2025 | Vachon Mark | director | U-Tender | Disposed | 1,252 | $3.00 |
| 3 Jun 2025 | Vachon Mark | director | D-Return | Disposed | 1,245 | $3.00 |
| 3 Jun 2025 | Colvin Richard A | Chief Medical Officer | U-Tender | Disposed | 3,552 | $3.00 |
| 3 Jun 2025 | Colvin Richard A | Chief Medical Officer | D-Return | Disposed | 2,500 | $3.00 |
| 3 Jun 2025 | Colvin Richard A | Chief Medical Officer | A-Award | Acquired | 2,500 | $3.00 |
| 28 May 2020 | Lois Frankel | Lois Frankel | Purchase | $1,001 - $15,000 |